Latest Posts
Resources
Epitope Mapping: Alanine Scanning Mutagenesis vs. HDX-MS
Written by: Genya Gorshtein, MSc Published: June 10, 2024 Contents Introduction Alanine Scanning Mutagenesis Epitope Mapping HDX-MS Epitope Mapping [...]
B Cell Sequencing and Polyclonal Sequencing Explained
Written by: Genya Gorshtein, MSc Published: December 12, 2024 Contents Introduction BCR and Single B Cell Sequencing for Antibody [...]
De Novo Sequencing a Bispecific T Cell Engager
Our client is a biotechnology company developing therapeutics that target cancer-specific carbohydrate antigens on the surface of tumour cells.
Antibody Affinity Insights with REpAb Antibody Discovery
Our client is a biotechnology company developing therapeutics that target cancer-specific carbohydrate antigens on the surface of tumour cells.
Functional Enrichment Strategies for Anti-Idiotypic Antibody Discovery
Our client is a biotechnology company developing therapeutics that target cancer-specific carbohydrate antigens on the surface of tumour cells.
SPR vs. ELISA: SPR Guides Accurate ELISA Results
Our client is a biotechnology company developing therapeutics that target cancer-specific carbohydrate antigens on the surface of tumour cells.
Developing CAR-T Therapies Against Novel Cancer Antigens
To develop robust mAb biologics, it is vital to fully characterize the protein, including its primary sequence, mutations, and important post-translational modifications
Synthetic Antigens Enable CAR-T Cell Targeting of Solid Tumors
To develop robust mAb biologics, it is vital to fully characterize the protein, including its primary sequence, mutations, and important post-translational modifications
From Plasma to Protection: Sequencing Inhibitory Antibodies Against Malaria
November 18, 2025 | 10:00AM EST In this webinar, you will learn: Explore how REpAb can sequence antibodies from the [...]
When Hybridomas Die: Recovering Critical Reagents with Antibody Sequencing
To develop robust mAb biologics, it is vital to fully characterize the protein, including its primary sequence, mutations, and important post-translational modifications
Rethinking Epitope-Based Patents for Stronger mAb Protection
In this webinar, you will learn: About paratope-centered patenting as a way to build stronger, structurally defined claims that withstand enablement [...]
Engineering and Kinetic Analysis of TNFɑ Inhibitory Nanobodies via SPR
To develop robust mAb biologics, it is vital to fully characterize the protein, including its primary sequence, mutations, and important post-translational modifications